YUE DA INTL (00629) enters into factoring agreement with YAXI Jingxuan

18:50 28/12/2025

Yue Da International Holdings (00629) announced that on December 25, 2025, its indirect wholly-owned subsidiary Yue Da Commercial Factoring entered into a factoring agreement (Yanxi Jingxuan Second Factoring Agreement) with Yanxi Jingxuan. Under the Yanxi Jingxuan Second Factoring Agreement, Yue Da Commercial Factoring agreed to provide accounts receivable financing, accounts receivable management services, and accounts receivable collection services to Yanxi Jingxuan, and granted a revolving credit limit of RMB 57 million. The annual interest rate and factoring management fee totaled 8.3% to 8.8%, and the agreement will be effective from December 25, 2025 to December 25, 2027.

YUE DA INTL (00629) announced that on December 25, 2025, the company's indirectly wholly-owned subsidiary Yueda Commercial Factoring entered into a factoring agreement with Yanxi Jingxuan (the Second Factoring Agreement). According to the Second Factoring Agreement with Yanxi Jingxuan, Yueda Commercial Factoring agreed to provide accounts receivable financing, accounts receivable management services, and accounts receivable collection services to Yanxi Jingxuan, and granted a revolving credit limit of 57 million RMB. The annual interest rate and factoring management fee totaled 8.3% to 8.8%, effective from December 25, 2025, and due on December 25, 2027.

BANK OF GUIZHOU (06199) elects Chen Rong as a member of the Nomination and Remuneration Committee.

China Minsheng Banking Corp., Ltd. (01988) nominated Zhang Zhen as a candidate for non-executive director.

JIANGXI BANK (01916): Pan Jianying appointed as company secretary and authorized representative.

BANK OF GUIZHOU (06199) elects Chen Rong as a member of the Nomination and Remuneration Committee.

China Minsheng Banking Corp., Ltd. (01988) nominated Zhang Zhen as a candidate for non-executive director.

JIANGXI BANK (01916): Pan Jianying appointed as company secretary and authorized representative.